Involvement of human cytochrome P450 3A4 in reduced haloperidol oxidation. [electronic resource]
Producer: 19981007Description: 253-9 p. digitalISSN:- 0031-6970
- Anti-Arrhythmia Agents -- pharmacology
- Anti-Bacterial Agents -- administration & dosage
- Antiparkinson Agents -- pharmacology
- Biotransformation -- drug effects
- Biperiden -- pharmacology
- Carteolol -- metabolism
- Cell Line, Transformed
- Cytochrome P-450 CYP2D6 -- metabolism
- Cytochrome P-450 CYP2D6 Inhibitors
- Cytochrome P-450 CYP3A
- Cytochrome P-450 Enzyme Inhibitors
- Cytochrome P-450 Enzyme System -- metabolism
- Dose-Response Relationship, Drug
- Haloperidol -- antagonists & inhibitors
- Humans
- Hydroxylation -- drug effects
- Isoenzymes -- antagonists & inhibitors
- Kinetics
- Microsomes -- drug effects
- Mixed Function Oxygenases -- antagonists & inhibitors
- Oxidation-Reduction -- drug effects
- Quinidine -- pharmacology
- Sparteine -- pharmacology
- Troleandomycin -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.